Phase 3 Donors Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Anesthesia sTrategy foR Organ Procurement In braiN dEath
Brain-dead Organ Donors
University Hospital, Grenoble270 enrolled1 locationNCT07166991
Active
Phase 3
Monitoring of iron status and clinical evaluation of interventions intended to maintain clinically adequate iron status in women who are new blood donors
Prevention of low iron status and iron deficiency in new female blood donors
Dr James M Faed5,100 enrolled1 locationACTRN12612000911897
Completed
Phase 3
A randomised, double blind, placebo controlled trial of the effectiveness of “post donation” short term iron replacement in female whole blood donors with a daily oral dose of 45 mgs elemental iron
Iron deficiency in female blood donors aged 18-45 years
Australian Red Cross Blood Service260 enrolled1 locationACTRN12609000496213